Back to top
more

Canopy Growth (CGC)

(Real Time Quote from BATS)

$5.58 USD

5.58
11,409,266

+0.72 (14.82%)

Updated Nov 4, 2024 02:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tilray Gains More Than 200%: Is There More Scope for Growth?

by Zacks Equity Research

Tilray (TLRY) gains more than 200% in the past six months. Strategic deals should propel further growth.

Canopy Growth Corporation (CGC) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Canopy Growth Corporation (CGC) closed at $28.23 in the latest trading session, marking a +0.43% move from the prior day.

Ryan McQueeney headshot

Upcoming Earnings to Watch: LEN, STZ, BBBY

by Ryan McQueeney

Stocks whipsawed this week, just in time for the first wave of earnings reports to help motivate the direction of the market. Let's take a closer look at a few of the earnings announcements due during the week of January 7.

Canopy Growth Corporation (CGC) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Canopy Growth Corporation (CGC) closed the most recent trading day at $27.34, moving +1.98% from the previous trading session.

AB InBev (BUD) Enters Booming Cannabis Realm With Tilray Deal

by Zacks Equity Research

AB InBev (BUD) announces partnership with the leading marijuana producer, Tilray.

Tilray Stock Up on Medical Cannabis Collaboration With Sandoz

by Zacks Equity Research

Tilray (TLRY) expands its previous collaboration deal with Sandoz, a generic arm of Novartis, to supply medical cannabis globally using the latter's supply chain.

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Canopy Growth Corporation (CGC) closed at $29.21, marking a -0.54% move from the previous day.

Sanghamitra Saha headshot

4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019

by Sanghamitra Saha

These are the factors that could send marijuana stocks and ETF high in 2019.

Ryan McQueeney headshot

3 Pot Stocks to Watch on Farm Bill & News from Trump, May, Retail Earnings

by Ryan McQueeney

Ryan McQueeney discusses President Trump's latest comments on the trade war and the impending vote of confidence facing U.K. Prime Minister Theresa May. He also recaps earnings results from the retail sector. Later, he highlights three cannabis stocks to watch as the farm bill passes.

Highlighted as Zacks Bull and Bear of the Day AeroVironment, Beacon Roofing Supply, Canopy Growth and Constellation

by Zacks Equity Research

Highlighted as Zacks Bull and Bear of the Day AeroVironment, Beacon Roofing Supply, Canopy Growth and Constellation

Ryan McQueeney headshot

Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest

by Ryan McQueeney

Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.

The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest

Cronos Group (CRON) Soars on C$2.4B Investment from Altria

by Zacks Equity Research

Cronos Group (CRON) receives a significant boost with C$2.4-billion equity investment from tobacco giant Altria Group.

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Canopy Growth Corporation (CGC) closed the most recent trading day at $31.02, moving -1.21% from the previous trading session.

Here's Why You Should Hold Constellation Brands Stock Now

by Zacks Equity Research

Constellation Brands (STZ) is a favored stock, owing to its robust surprise trend, strength in the beer business and solid business growth plans, including investment in Canopy Growth.

Sweta Killa headshot

Cronos-Altria Deal Boost Marijuana ETF: Will This Continue?

by Sweta Killa

Altria investment in Canadian cannabis producer Cronos sparked a rally in the broad cannabis sector and the its ETF. Will the trend continue?

Are Options Traders Betting on a Big Move in Canopy Growth (CGC) Stock?

by Zacks Equity Research

Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.

Ryan McQueeney headshot

Are There Any Dividend-Paying Cannabis Stocks?

by Ryan McQueeney

Cannabis stocks have been one of the investing world's top stories in 2018, but for many, these speculative plays are far too unpredictable. Are there any stable, dividend-paying marijuana stocks to buy right now?

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Canopy Growth Corporation (CGC) closed at $33.33 in the latest trading session, marking a -0.66% move from the prior day.

Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Canopy Growth Corporation (CGC) closed at $31.70 in the latest trading session, marking a +0.48% move from the prior day.

Nitish Marwah headshot

Legal Pot Shops & Likely IPOs: Is Hemp the Next Big Thing?

by Nitish Marwah

Increasing tolerance and gradual legalization of marijuana has been an increasing trend across America.

Sanghamitra Saha headshot

Top and Flop ETFs of Last Week

by Sanghamitra Saha

Inside the winning and losing ETFs of the last week.

Company News For Nov 15, 2018

by Zacks Equity Research

Companies In The News Are: CGC,GOOS,SNAP,PENN

Sanghamitra Saha headshot

What Went Wrong With the Marijuana ETF on Wednesday?

by Sanghamitra Saha

Downbeat earnings have weighed on the marijuana ETF lately. Should you buy the dip or wait on the sidelines?

Canopy Growth Corporation (CGC) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -484.62% and -30.27%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?